Bringing the fundamentals into focus…
Back to BioMarin Pharmaceutical Inc.
How BioMarin Pharmaceutical Inc. stacks up
BMRN · against 1,336 other Healthcare companies
Valuation
41/ 100
Below the middle of the pack.
Ranked #783 of 1,337 · scores higher than 41% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 40–49, including BMRN · Click a bar to see the companies
Why valuation scores 41?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 0.7% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 2.1% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 87% of peers. Free cash flow yield: 6.9% vs peer median 0.0%
Metric by metric
Position: dot = BMRN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BMRN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 0.7% | 1.5% | 44% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 4.6% | 4.2% | 53% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 6.7% | -1.0% | 87% | 20% | |
| Book yieldHigher is better · 1,306 reported | 58.7% | 37.9% | 68% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around BMRN| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 783 | 148M AUD (≈$98M) | 41 | 39 | |
| 783 | 7.7B USD | 41 | 37 | |
| 783 | 593.2B INR (≈$7.1B) | 41 | 47 | |
| 783 | 13.2B USD | 41 | 30 | |
| 783 | 10.8B USD | 41 | 41 | |
| 783 | 449M USD | 41 | 72 | |
| 783 | 12.6B USD | 41 | 65 | |
| 783 | 639M AUD (≈$422M) | 41 | 55 | |
| 783 | 1.6B USD | 41 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score